Linde Gas: FDA Observes Serious Problems with NOxBOXi Device that Led to Neonatal Deaths and Injuries; Company Repeatedly Failed to Identify Patterns in Malfunctions, Investigate and Address Known Issues That Could Cause Death, and Report Problems to the FDA

Published on Oct 06, 2025

Linde Gas (LIN), the world’s largest industrial gas supplier, repeatedly failed to appropriately investigate and fix serious problems with its NOxBOXi device, which administers inhaled nitric oxide therapy to newborns and monitors nitrogen dioxide and oxygen levels, according to a July inspection report obtained by The Capitol Forum through a Freedom of Information Act Request. […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2025 The Capitol Forum. All Rights Reserved.